title: Combination enoxaparin-abciximab therapy during coronary intervention: the next standard of care?
authors.affiliation: The Carl and Edyth Lindner Center for Research and Education, 2123 Auburn Avenue, Suite #424, Cincinnati, OH 45219, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Tramuta
authors.forename: D J
authors.initials: DJ
authors.lastname: Kereiakes
authors.forename: E J
authors.initials: EJ
authors.lastname: Dippel
authors.forename: R
authors.initials: R
authors.lastname: Lengerich
authors.forename: T M
authors.initials: TM
authors.lastname: Broderick
authors.forename: C W
authors.initials: CW
authors.lastname: Abbottsmith
authors.forename: D D
authors.initials: DD
authors.lastname: Whang
authors.forename: E M
authors.initials: EM
authors.lastname: Roth
authors.forename: J F
authors.initials: JF
authors.lastname: Schneider
authors.forename: W
authors.initials: W
authors.lastname: Howard
authors.forename: T M
authors.initials: TM
authors.lastname: Shimshak
mesh_terms: D000077284:Abciximab; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D017023:Coronary Angiography; D001026:Coronary Artery Bypass / Q000009:adverse effects* / Q000379:methods; D023921:Coronary Stenosis / Q000000981:diagnostic imaging / Q000601:surgery; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D017984:Enoxaparin / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D008297:Male; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014654:Vascular Patency
chemical_list: D000911:Antibodies, Monoclonal; D017984:Enoxaparin; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab